Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Artemis Therapeutics Inc (ATMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,365
  • Shares Outstanding, K 5,154
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,140 K
  • 36-Month Beta 0.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2601 +1.88%
on 01/16/19
0.4000 -33.75%
on 01/16/19
-0.3351 (-55.84%)
since 12/31/18
3-Month
0.2601 +1.88%
on 01/16/19
0.8450 -68.64%
on 12/11/18
-0.4430 (-62.57%)
since 11/08/18
52-Week
0.2601 +1.88%
on 01/16/19
1.5000 -82.33%
on 02/12/18
-1.3350 (-83.44%)
since 01/30/18

Most Recent Stories

More News
Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

SAN DIEGO , April 16, 2018 /PRNewswire/ --  Artemis Therapeutics, Inc . (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening...

ATMS : 0.2650 (unch)
Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, today announced the...

ATMS : 0.2650 (unch)
INKSD : 0.7801 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ATMS with:

Key Turning Points

2nd Resistance Point 0.2650
1st Resistance Point 0.2650
Last Price 0.2650
1st Support Level 0.2650
2nd Support Level 0.2650

See More

52-Week High 1.5000
Fibonacci 61.8% 1.0264
Fibonacci 50% 0.8801
Fibonacci 38.2% 0.7337
Last Price 0.2650
52-Week Low 0.2601

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar